NOT-AG-21-030: Notice of Change to Award Information for RFA-AG-22-018 Leveraging Existing Large Databases and Cohorts to Better Understand the Risks and Benefits of Long-Term Osteoporosis Therapy and Drug Holiday (R01 Clinical Trial Not Allowed)

Notice of Change to Award Information for RFA-AG-22-018 “Leveraging Existing Large Databases and Cohorts to Better Understand the Risks and Benefits of Long-Term Osteoporosis Therapy and Drug Holiday (R01 Clinical Trial Not Allowed)

Notice Number:

NOT-AG-21-030

Key Dates

Release Date:

June 28, 2021

Related Announcements

RFA-AG-22-018 - Leveraging Existing Large Databases and Cohorts to Better Understand the Risks and Benefits of Long-Term Osteoporosis Therapy and Drug Holiday (R01 Clinical Trial Not Allowed)

Issued by

National Institute on Aging (NIA)

Purpose

This Notice informs potential applicants of the following changes to the Funds Available and Anticipated Number of Awards for Funding Opportunity Announcement (FOA) RFA-AG-22-018 "Leveraging Existing Large Databases and Cohorts to Better Understand the Risks and Benefits of Long-Term Osteoporosis Therapy and Drug Holiday (R01 Clinical Trial Not Allowed)". NIA is including NIAMS' funding information.

The following Sections of RFA-AG-22-018 have been modified:

Currently Reads:

Part 2. Full Text of Announcement

Section II. Award Information

Funds Available and Anticipated Number of Awards: NIA intends to commit $2,500,000 in FY 2022 to fund 2-3 awards.

Modified to Read (changes shown in bold italics):

Part 2. Full Text of Announcement

Section II. Award Information

Funds Available and Anticipated Number of Awards: NIA intends to commit $2,500,000 in FY 2022 to fund 2-3 awards. NIAMS intends to commit $750,000 in FY2022 to fund up to 1 award.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Lyndon Joseph, Ph.D.
National Institute on Aging (NIA)
Telephone: 301-496-6761
Fax: 301-402-1784
Email: [email protected]